| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
n
kMax-Delbrück-Center for Molecular Medicine D-13122 Berlin, Germany
Nuclear receptors are important regulators of
erythroid cell development. Here we investigated the impact of retinoid
X receptor (RXR), retinoic acid receptor (RAR), and of the
c-erbA/thyroid hormone (T3) receptor
(c-erbA/TR) on growth and differentiation of erythroid cells using an
in vitro culture system of stem cell
factor-dependent erythroid progenitors. RXR, RAR, and
c-erbA/TR-specific ligands were found to induce erythroid-specific gene
expression and to accelerate erythroid differentiation in culture, with
T3 being most effective. Furthermore, while
ligand-activated c-erbA/TR accelerated differentiation, unliganded
c-erbA/TR effectively blocked differentiation and supported sustained
progenitor growth in culture. Thus, c-erbA/TR appears to act as a
binary switch affecting erythroid cell fate: unliganded c-erbA/TR
supports growth while ligand-activated c-erbA/TR induces
differentiation. Additionally, to determine the impact of RXR for
erythroid cell development, dominant interfering mutant RXRs, lacking
the transcriptional activator functions AF-1 and AF-2, or AF-2 only, or
the entire DNA-binding domain, were introduced into erythroid
progenitor cells via recombinant retrovirus vectors and analyzed for
RXR-specific effects. It was found that expression of wild-type RXR and
of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient
outgrowth of erythroid cells. In marked contrast, expression of the
dominant interfering
DNA-binding domain RXR, containing a deletion
of the entire DNA-binding domain, was incompatible with erythroid cell
growth in vitro, suggesting a pivotal role of RXR for
erythroid cell development.
This article has been cited by other articles:
![]() |
K.-R. Koh, M. Janz, M. Y. Mapara, B. Lemke, D. Stirling, B. Dorken, M. Zenke, and S. Lentzsch Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis Blood, May 15, 2005; 105(10): 3833 - 3840. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Angelin-Duclos, C. Domenget, A. Kolbus, H. Beug, P. Jurdic, and J. Samarut Thyroid hormone T3 acting through the thyroid hormone {alpha} receptor is necessary for implementation of erythropoiesis in the neonatal spleen environment in the mouse Development, March 1, 2005; 132(5): 925 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kamiya, M. Puzianowska-Kuznicka, P. McPhie, J. Nauman, S.-y. Cheng, and A. Nauman Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma Carcinogenesis, January 1, 2002; 23(1): 25 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Karafiat, M. Dvorakova, P. Pajer, J. Kralova, Z. Horejsi, V. Cermak, P. Bartunek, M. Zenke, and M. Dvorak The leucine zipper region of Myb oncoprotein regulates the commitment of hematopoietic progenitors Blood, December 15, 2001; 98(13): 3668 - 3676. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ingley, D. Chappell, S. Y. K. Poon, M. K. Sarna, J. G. Beaumont, J. H. Williams, J. P. Stillitano, S. Tsai, P. J. Leedman, P. A. Tilbrook, et al. Thyroid Hormone Receptor-interacting Protein 1 Modulates Cytokine and Nuclear Hormone Signaling in Erythroid Cells J. Biol. Chem., November 9, 2001; 276(46): 43428 - 43434. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Koritschoner, J. Madruga, S. Knespel, G. Blendinger, B. Anzinger, A. Otto, M. Zenke, and P. Bartunek The Nuclear Orphan Receptor TR4 Promotes Proliferation of Myeloid Progenitor Cells Cell Growth Differ., November 1, 2001; 12(11): 563 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhu, C. M. Heyworth, A. Glasow, Q.-H. Huang, K. Petrie, M. Lanotte, G. Benoit, R. Gallagher, S. Waxman, T. Enver, et al. Lineage restriction of the RAR{alpha} gene expression in myeloid differentiation Blood, October 15, 2001; 98(8): 2563 - 2567. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Panzenbock, P. Bartunek, M. Y. Mapara, and M. Zenke Growth and Differentiation of Human Stem Cell Factor/Erythropoietin-Dependent Erythroid Progenitor Cells In Vitro Blood, November 15, 1998; 92(10): 3658 - 3668. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |